Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Hsieh

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2010
Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancerAndrew C Hsieh, Davide Ruggero
Asian Journal of Andrology|April 25, 2014
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistanceMerritt P Edlind, Andrew C Hsieh
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Novel concepts in androgen receptor blockadeAndrew C Hsieh, Charles J Ryan
Trends in Cancer|April 10, 2019
The Untranslated Regions of mRNAs in CancerSamantha L Schuster, Andrew C Hsieh
Cell Death & Disease|October 6, 2017
Reciprocal amplification of caspase-3 activity by nuclear export of a putative human RNA-modifying protein, PUS10 during TRAIL-induced apoptosisSujata Jana, Andrew C Hsieh, Ramesh Gupta
Cancer Research|December 15, 2023
Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate CancerRashmi Mishra, Steven Blinka, Andrew C Hsieh
Trends in Molecular Medicine|June 23, 2023
ELAC2 is a functional prostate cancer risk alleleSteven Blinka, Rashmi Mishra, Andrew C Hsieh
European Urology Focus|August 1, 2022
Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer DiscoveryYeon Soo Kim, Andrew C Hsieh, Hung-Ming Lam
The Lancet. Oncology|October 5, 2007
Androgen-response elements in hormone-refractory prostate cancer: implications for treatment developmentAndrew C Hsieh, Eric J Small, Charles J Ryan
Bioinformatics (Oxford, England)|September 20, 2013
Assessing gene-level translational control from ribosome profilingAdam B Olshen, Andrew C Hsieh, Craig R Stumpf, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2010
Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancerAndrew C Hsieh, Davide Ruggero
Asian Journal of Andrology|April 25, 2014
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistanceMerritt P Edlind, Andrew C Hsieh
Cancer Journal (Sudbury, Mass.)|February 28, 2008
Novel concepts in androgen receptor blockadeAndrew C Hsieh, Charles J Ryan
Trends in Cancer|April 10, 2019
The Untranslated Regions of mRNAs in CancerSamantha L Schuster, Andrew C Hsieh
Cell Death & Disease|October 6, 2017
Reciprocal amplification of caspase-3 activity by nuclear export of a putative human RNA-modifying protein, PUS10 during TRAIL-induced apoptosisSujata Jana, Andrew C Hsieh, Ramesh Gupta
Cancer Research|December 15, 2023
Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate CancerRashmi Mishra, Steven Blinka, Andrew C Hsieh
Trends in Molecular Medicine|June 23, 2023
ELAC2 is a functional prostate cancer risk alleleSteven Blinka, Rashmi Mishra, Andrew C Hsieh
European Urology Focus|August 1, 2022
Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer DiscoveryYeon Soo Kim, Andrew C Hsieh, Hung-Ming Lam
The Lancet. Oncology|October 5, 2007
Androgen-response elements in hormone-refractory prostate cancer: implications for treatment developmentAndrew C Hsieh, Eric J Small, Charles J Ryan
Bioinformatics (Oxford, England)|September 20, 2013
Assessing gene-level translational control from ribosome profilingAdam B Olshen, Andrew C Hsieh, Craig R Stumpf, et al.
Pageof 7